CHIARINI, FRANCESCA

CHIARINI, FRANCESCA  

DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE  

Personale esterno ed autonomi  

Risultati 1 - 20 di 38 (tempo di esecuzione: 0.023 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells Alessandro Poli; Irene Faenza; Alessandro Matteucci; Francesca Chiarini; Lucio Cocco 2012-01-01 - - 4.03 Poster -
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. F. Chiarini; C. Grimaldi; F. Ricci; P. L. Tazzari; C.Evangelisti; A. Ognibene; M.Battistelli; E. Falcieri; F. Melchionda; A. Pession; P. Pagliaro; J.A. McCubrey; A.M. Martelli. 2010-01-01 CANCER RESEARCH - 1.01 Articolo in rivista -
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy McCubrey J.A.; Sokolosky M.L.; Lehmann B.D.; Taylor J.R.; Navolanic P.M.; Chappell W.H.; Abrams S.L.; Stadelman K.M.; Wong E.W.; Misaghian N.; Horn S.; Bäsecke J.; Libra M.; Stivala F.; Ligresti G.; Tafuri A.; Milella M.; Zarzycki M.; Dzugaj A.; Chiarini F.; Evangelisti C.; Martelli A.M.; Terrian D.M.; Franklin R.A.; Steelman L.S. 2008-01-01 - Elsevier Ltd. 2.01 Capitolo / saggio in libro -
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. Grimaldi C.; Chiarini F.; Tabellini G.; Ricci F.; Tazzari P.L.; Battistelli M.; Falcieri E.; Bortul R.; Melchionda F.; Iacobucci I.; Pagliaro P.; Martinelli G.; Pession A.; Barata J.T.; McCubrey J.A.; Martelli A.M. 2012-01-01 LEUKEMIA - 1.01 Articolo in rivista -
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Bressanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am 2014-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine Carano F.; Teti G.; Ruggeri A.; Chiarini F.; Giorgetti A.; Mazzotti M.C.; Fais P.; Falconi M. 2021-01-01 SCIENTIFIC REPORTS - 1.01 Articolo in rivista -
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm Teti G.; Chiarini F.; Mazzotti E.; Ruggeri A.; Carano F.; Falconi M. 2021-01-01 MECHANISMS OF AGEING AND DEVELOPMENT - 1.01 Articolo in rivista -
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES Buontempo, Francesca; Orsini, E; Cappellini, Alessandra; Lonetti, Annalisa; Evangelisti, C; Chiarini, Francesca; Spartà, Am; Bressanin, D; Evangelisti, C; Martelli, Am 2014-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
Dual inhibition of class IA phoshatidylinositol 3-kinase and mTOR as a new therapeutic option for T-cell acute lymphoblastic leukemia. F. Chiarini; F. Falà; P. L. Tazzari; F. Ricci; A. Astolfi; A. Pession; P. Pagliaro; J.A. McCubrey; A.M. Martelli. 2009-01-01 CANCER RESEARCH - 1.01 Articolo in rivista -
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco 2009-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco 2011-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology. A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; J.A. McCubrey. 2010-01-01 CANCERS - 1.01 Articolo in rivista cancers-02-01576.pdf
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. A.M. Martelli; V. Papa; P.L. Tazzari; F. Ricci; C. Evangelisti; F. Chiarini; C. Grimaldi; A. Cappellini; G. Martinelli; E. Ottaviani; P. Pagliaro; S. Horn; J. Bäsecke; L.H. Lindner; H. Eibl; J.A. McCubrey. 2010-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml Lonetti A.; Indio V.; Laginestra M.A.; Tarantino G.; Chiarini F.; Astolfi A.; Bertuccio S.N.; Martelli A.M.; Locatelli F.; Pession A.; Masetti R. 2020-01-01 CANCERS - 1.01 Articolo in rivista cancers-12-01972.pdfcancers-12-01972-s001.zip
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. Fiume R; Ramazzotti G; Teti G; Chiarini F; Faenza I; Mazzotti G; Billi AM; Cocco L 2009-01-01 THE FASEB JOURNAL - 1.01 Articolo in rivista -
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion Chiarini F, Balestra T, Fazio A, Paganelli F, Maltarello MC, Evangelisti C, Capanni C, Petrini S, Martelli AM, Lattanzi G, Scotlandi K 2019-01-01 - - 4.03 Poster -
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells Camilla Evangelisti, Francesca Paganelli, Gaia Giuntini, Elisabetta Mattioli, Alessandra Cappellini, Giulia Ramazzotti, Irene Faenza, Maria Cristina Maltarello, Alberto M. Martelli, Katia Scotlandi, Francesca Chiarini, Giovanna Lattanzi 2020-01-01 CELLS - 1.01 Articolo in rivista cells-09-00774.pdfcells-09-00774-s001.zip
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. Annalisa Lonetti, Alessandra Cappellini, Antonino Maria Spartà, Francesca Chiarini, Francesca Buontempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, James A. McCubrey, Alberto Maria Martelli 2015-01-01 ONCOTARGET - 1.01 Articolo in rivista PI3K pan inhibition impairs more efficiently proliferation and survival of T cell acute lymphoblastic leukemia cell lines when compared to isoform selective PI3K inhibitors..pdf
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. Falà F; Blalock WL; Tazzari PL; Cappellini A; Chiarini F; Martinelli G; Tafuri A; McCubrey JA; Cocco L; Martelli AM 2008-01-01 MOLECULAR PHARMACOLOGY - 1.01 Articolo in rivista -
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells V. Papa; P.L. Tazzari; F. Chiarini; A. Cappellini; F. Ricci; A.M. Billi; C. Evangelisti; E. Ottaviani; G. Martinelli; N. Testoni; J.A. McCubrey; A.M. Martelli 2008-01-01 LEUKEMIA - 1.01 Articolo in rivista -